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Abstract
Background: HIV self-testing (HIVST), especially the secondary distribution of HIVST (SD-HIVST) initiated by sexual
health influencers (SHIs), has been recognized as an effective strategy in promoting HIV testing, especially among men
who have sex with men (MSM). This quasi-experimental study aimed to evaluate whether SHIs identified through the
ensemble machine learning approach can distribute more HIVST than those who identified by the empiricalscale.
Methods: We will recruit eligible adults (≥18 years old) who were assigned male gender at birth, and willing to
participate in potential SD-HIVST online. Participants will be assigned randomly to two groups (scale group or machine
learning group), followed by a separate process of SHI identification based on the group assignment. After
identification, all index participants (defined as identified SHIs who are verbally consented to participate in SD-HIVST or
who directly order HIVST kits) will follow the same procedure for SD-HIVST acquisition and distribution. Index
participants can order HIVST online and distribute them to members within their social networks (defined as
alters) in-person or virtually through a personalized peer referral link. Once a unique alter uploads a
photographed test result to the platform, both the alter and the corresponding index participant will receive
a fixed incentive of 3 USD. The index MSM can order up to five HIVST in the first three months and ten HIVS
T in the following three months. Each index participant will need to complete a baseline survey at the first-
time ordering and one to two follow-upbased on the times of ordering,, three months after ordering. This
trial will be comparing 1) the mean number of alters motivated by each index participant in each group and
2) the mean number of newly-tested alters motivated by each index participant in each group.
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Discussion: In promoting the efficacy of identifying SHIs for SD-HIVST, our study has the potential to
enhance testing coverage, particularly among marginalized individuals and those who are reluctant to for HIV
and other sexually transmitted infections.
Trial registration: We registered the study on the Chinese Clinical Trial Registry website on 4th November
2021, with registration number ChiCTR2000039632.
Keywords: Sexual health influencers, Ensemble machine learning, Secondary distribution, HIV self-testing, Men
who have sex with men, China
Background
The global human immunodeficiency virus (HIV) epi-
demic has been well controlled [1, 2]. However, study
findings still reinforce the need for further attention to
men who have sex with men (MSM) regarding HIV pre-
vention. For instance, the HIV prevalence among MSM
in China has increased from 0.5% in 2003 to 8.0% in
2015 and stays consistent afterward, while this also con-
sistently stands highly of HIV incidence in China [3–5].
The lack of HIV status awareness is one of the main
identified reasons for the high HIV infection rate among
the MSM population [1]. Unfortunately, a recent statistic
showed that more MSM in China (about 40–50%) than
in other developed countries are less likely to have tested
for HIV in the last 12 months [6]. Therefore, HIV testing
is considered the key and the first step needed in HIV
transmission prevention, specifically among MSM [7].
Following testing, the need for successful linkage to care
and treatment for all diagnosed persons living with HIV
is also quite essential.
Compared with healthcare facilities-based tests, HIV
self-testing (HIVST) affords users greater convenience,
autonomy, and privacy [8, 9]. HIVST is recognized glo-
bally as an innovative and reliable strategy to promote
HIV testing. The World Health Organization (WHO)
also recommends HIVST as an efficient testing approach
for persons with low access to testing services and high-
at-risk persons for routine testing [10]. Secondary distri-
bution of HIVST kits (SD-HIVST) refers to a strategy
where individuals (defined as index) obtain multiple
HIVST kits and distribute them to members within their
social networks (defined as alters) [11]. Currently, a
growing number of empirical pieces of evidence have
shown that SD-HIVST could contribute to the increas-
ing coverage of HIV testing and effectively promote HIV
case identification in diverse populations [12–14].
In addition, individuals within centralized networks
could contribute to health behavior change among their
peers [15] and increase the distribution of HIV self-
testing kits [16] through SD-HIVST. How to effectively
identify sexual health influencers (SHIs) among MSM is
relevant in implementing SD-HIVST interventions.
However, most preliminary studies employ self-reporting
or empirical scales that cannot evaluate SHIs’ social net-
work characteristics and have limited influence [17–21].
Therefore, we developed an ensemble machine learning
model to help identify key SHIs [22]. This quasi-
experimental trial sought to examine if SHIs identified
through our trained ensemble machine learning model
can facilitate more testing among persons who receive
HIVST in the SD-HIVST intervention.
Objectives
This trial aims to examine whether the SHIs identified
by an ensemble machine learning model can motivate
more alters to receive HIVST kits and more first-timers
to test for HIV, compared to SHIs identified through an
empirical scale.
Hypothesis
We hypothesize that SHIs identified by the ensemble
machine learning model will motivate more alters to test
and identify more newly-tested alters (as first-time tested
for HIV) through the SD-HIVST intervention than SHIs
identified by the conventional scale.
Trial design
This trial will be a double-blinded, quasi-experimental
study with two parallel groups. The study duration is 12
months, from January 2021 to December 2021. We will
randomly assign study participants into two groups in a
1:1 allocation ratio after recruitment. After that, we will
use two distinct strategies (model-based and scale-based
methods) in identifying the SHIs within each group who
will receive the same intervention (SD-HIVST).
Methods/design
Study setting and recruitment
The study will be conducted jointly by the Social Entre-
preneurship to Spur Health (SESH) team, Zhuhai Center
for Diseases Control and Prevention (CDC), and Zhuhai
Xutong Voluntary Services Center (Xutong), which is an
MSM-friendly community-based organization (CBO).
We will post recruitment banner adverts on Blued, the
largest online gay social networking application among
MSM in China, in 5 provinces of southern China
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(Guangdong, Guangxi, Fujian, Hunan, Jiangxi). Inter-
ested MSM who click the banner posts will undergo an
eligibility assessment using a set of pre-survey questions,
and eligible participants will proceed to complete an
online baseline survey.
Eligibility criteria
To participate in the study, interested individuals are
must meet the following criteria: 1) be assigned male
gender at birth; 2) be at least 18 years or older; 3) self-
report ever having sex with other men, and 4) be willing
to participate in a potential secondary distribution of
HIVST intervention.
Interventions
We will randomly allocate eligible participants to either
the scale group as controls or machine learning groupas
the intervention group. A statistician will identify SHIs
in the intervention group using an ensemble machine
learning model and using a conventional scale for identi-
fication in the control group. All identified SHIs will be
eligible to participate in the SD-HIVST intervention as
index participants. We define index participants as those
who were consented to participate in the program.
Index participants from both groups will follow the
same study procedures for SD-HIVST with monetary
incentives plus peer referral. They will be required to
complete a survey at the beginning of the first-time
ordering and one follow-up survey three months after
each time they order HIVST kits. Figure 1 is the flowchart
which shows the trial procedures.
The scale group/ control group
SHIs among MSM participants assigned to the empiri-
calscale group (hereafter, scale group) will be determined
using a 6-item scale. The same scale has been used by
our team in a previous study [22, 23] to measure men’s
sexual health influence, with a Cronbach alpha of 0.937.
The scale consists of six questions that will assess each
participants’ level of contribution in spreading HIV and
sexually transmitted infections (STI) related information
both online and offline in the past three months. The six
questions include 1) how often they talked to others
about HIV and STI; 2) how much information about
HIV and STI they provided to others; 3) how many
people they told about HIV and STI; 4) how likely they
were to ask for more information about HIV and STI; 5)
who communicated more information about HIV and
STI: the participants or others within their social net-
work; 6) how often they were to ask for advice about
HIV and STI. Total response scores from answering the
questions range from 0 to 24. Table 1 presents a detailed
summary of responses to each question.
We may eliminate some top-point indexes (by either
20% or 30%, or other percentages) depending on the ac-
tual situation we encounter during the data collection.
Also, the machine learning identification of the number
of SHIs will be according to the ranking descending
from the highest total points. We will randomly select
the required number of indexes amongst the eligible
SHIs with the lowest scale total scale point if more
indexes share the same total scale point score. For ex-
ample, if we would like to cut off the top 35 indexes out
of 100 participants, however, 27 indexes scored at least
20 points, and the subsequent 12 indexes (Rank No. 28
to Rank No. 39) score 19 points, then we will randomly
select eight indexes among the 12 indexes (i.e., No. 28 to
No. 39). That will ensure that the cut-off percentage of
35% predefined before the selection will remain equal to
the same number of machine learning identification
results.
The machine learning group/ intervention group
SHIs in the intervention group will be identified using
an ensemble machine learning model, which we have
trained using our previous SD-HIVST intervention
trial data [24]. The data from our prior SD-HIVST
intervention pilot served as our training and valid-
ation data set. And the identification of the results
(i.e., classification accuracy) of our proposed machine
learning model outperformed the conventional scales
cut-off method [22].
We determined significant predictors according to
machine learning algorithms, using training dataset and
validation dataset in our previous modeling study [22].
Thus, we will include questions regarding these predic-
tors in the baseline survey. We will collect data on
these selected predictors and input them into our pre-
trained ensemble machine learning model. Output
results from the model will show who the SHIs are in
the machine learning group. If some predictor variables
have unavailable or missing data, our model will still
work as we can regard those data as ‘NA’ data in
modeling input for prediction. Also, we trained three
ensemble machine learning models in our previous
modeling study for identifying SHIs. The models could
distinctly predict key distributors (SHIs who are likely
to distribute at least two kits to alters), key promotors
(SHIs who can promote HIV testing among the first-
time tested alters), and key detectors (SHIs who can
contribute to positive alters detection). However, we
found that the model of key distributors is also capable
of identifying most of key promotors. Therefore, in this
study, we will utilize the model of key distributors for
SHI identification in the machine learning group as our
main outcomes focus on the ability of index on motiv-
ating alters and newly-tested alters.
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Fig. 1 Trial Flowchart
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Procedure of secondary distribution of HIVST
All index participants will follow the one standard set of
instructions and procedures for network-based online
SD-HIVST regardless of group assignment. This proced-
ure has been used in our previous studies and has shown
effectiveness in increasing HIV testing coverage among
Chinese MSM [24–26]. Ordering of HIVST kits and
uploading test results will be all conducted using an on-
line digital platform created and operated by a commu-
nity health services center. Index participants can access
this platform by following the public account of Xutong
on WeChat, which is the largest social networking appli-
cation in China.
Alters will be encouraged to perform all HIVST
according to the manufacturers’ instructions using
fingerstick blood samples. We will use SD Bioline HIV/
Syphilis duo test kits (SD Bioline Company, South
Korea). Each HIVST kit will have a delivery-tracking
code, a result-tracking code, and a user guide manual at-
tached to it. HIVST kits will be delivered to the destin-
ation address provided by applicants at request by post.
The trained CBO staff verifies results based on photos
uploaded by testers. Testers will be required to submit
the testing evidence and test results by uploading photo-
graphs of their used kits to an online platform. That
platform will be an anonymous system that testers can
only access by scanning a QR code attached to their test
kit box.
There will be two rounds for index participants to
order HIVST kit(s) via the online platform. During the
first three months, index participants can request at
most five (5) HIVST kits based on their personal needs.
They can personally use the kits or distribute them to
others within their social network (hereafter, alters). In
addition, index participants can order a personalized
peer referral link, with which they can invite up to 5
unique alters to order one HIVST kit each. We will em-
ploy a refundable deposit strategy to reach a consider-
able response rate and facilitate linkage to care services.
We will demand a refundable deposit amount of 40
RMB (≈ 7 USD) at each request. The deposit will be
returned to the matched kit applicant through the same
payment method within three business days after an
uploaded testing result is verified by CBO staff.
All index participants will receive notification to order
the second round of HIVST kits after completing the 3-
month follow-up survey. Index participants who do not
finish the 3-month follow-up survey will receive a survey
reminder alongside the notice of the second round. For
index participants who do not order any test kits during
the first round, we will notify them about the second
round when the first index participant completes the
first follow-up survey. The only difference between the
two rounds is that an index participant can be allowed
to order up to 10 HIVST kits (5 HIVST kits in the first
round) and can invite up to 10 unique alters (5 alters in
the first round) to order one kit via the peer-referral link
during the second round.
For results verification, trained CBO staff will first read
test results according to uploaded photos. If a result is
determined to be invalid, we will contact the tester via
WeChat or phone call and ask whether the tester is will-
ing to get re-tested. If a result is HIV-reactive or
syphilis-reactive, the CBO staff will contact the teste to
provide linkage to care and support services. The CBO
staff will also verify the alters’ identification (by checking
Table 1 Summarized responses of each item in the conventional scale
Typical item Responses Categories Method of scaling
In the past 3 months, how often did you talk to
others about HIV and STI (including both online and
offline)?
Never, seldom, sometimes, often, always. 5-point Likert scale, from 0 (never)
to 4 (always).
In the past 3 months, how much information about
HIV and STI did you provide to others (including both
online and offline)?
No information provided, provided with a little
information, provided with some information,
provided with much information, provided with
massive information.
5-point Likert scale, from 0 (no
information provided) to 4 (provided
with massive information).
In the past 3 months, how many people did you tell
about HIV and STI (including both online and offline)?
None, few people, some people, many people, a lot
of people.
5-point Likert scale, from 0 (none), 4
(a lot of people).
In the past 3 months, how likely were you to be asked
for more information about HIV and STI (including
both online and offline)?
Very unlikely, unlikely, neutral, likely, very likely. 5-point Likert scale, from 0 (very
unlikely) to 4 (very likely).
In the past 3 months, who communicated more
information about HIV and STI: you or others within
your social network (including both online and
offline)?
All information was told by others, most of
information was told by others, information that
others told me about was as much as I told them,
most of information was told by me, all information
was told by me.
5-point Likert scale, from 0 (all
information was told by others) to 4
(all information was told by me).
In the past 3 months, how often were you to be
asked for advice about HIV and STI (including both
online and offline)?
Never, seldom, sometimes, often, always. 5-point Likert scale, from 0 (never)
to 4 (always).
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if the telephone number and WeChat ID provided by an
alter are the same as the corresponding index partici-
pant). Only index participants that distribute HIVST to
alters who use a different phone number and WeChat to
upload test results will receive incentives. A fixed
amount of 20 RMB (≈ 3 USD) will be offered to the cor-
responding index participant as a financial incentive
once an alters’ test result is verified. Additionally, all
testers will receive a fixed 20 RMB (≈ 3 USD) as encour-
agement and honorarium for their time used when a
CBO staff validates their results for the first time.
Outcomes
Our first primary outcome is to compare the average
number of alters motivated by each index between two
groups. The second primary outcome is to ascertain the
mean number of newly-tested alters motivated by each
index in each group in the same study period. Secondary
outcomes will be 1) the mean number of tested alters
motivated by each index in each group with HIV react-
ive results, and 2) evaluate the primary outcomes in
subgroups categorized by age, sexual orientation, sexual
intercourse history, residence, and previous HIV testing
experience.
Participant timeline
We expect to start study recruitment from January 7,
2021, to January 22, 2021. Randomizing recruited partic-
ipants into groups, identifying SHIs for each group, and
notifying participants occurred in February 2021. The
first round of HIVST orders starts from February 2021
to April 2021, and the second round of HIVST requests
will be from June 2021 to July 2021. Follow-up surveys
will be collected three months later following each or-
dering. The trial ends in October 2021.
Sample size
We use PASS version 16.0 to calculate a study sample
size of 400 index participants (200 in each group), with
an alpha of 0.05 and a loss to follow-up of 20%. Our esti-
mated sample size can provide a power of 0.80 to detect
differences between groups and are calculated based on
the following assumptions.
Assumption 1
We assumed that SHIs identified by the model could
motivate one more alter on average to get tested for
HIV than SHIs identified by the scale, based on the
results of our previous study [21].
Assumption 2
Based on the results of our previous study [25], we as-
sumed that 40% of alters motivated by SHIs identified by
the scale will be new testers. We also estimate that SHIs
identified by the model can motivate 0.3 more newly-
tested alters than SHIs identified by scale [22].
Recruitment
The recruitment banner ads will have a brief trial de-
scription and continue showing on Blued until a target
population size of at least 2000 eligible MSM partici-
pants fills in the baseline survey. Each Blued user will
only be able to finish the baseline survey once. After sur-
vey submission, eligible study participants will receive a
random 8-digit verification code and the WeChat ID of
SESH. All participants will be encouraged to add the
SESH official WeChat and provide their unique 8-digit
verified code to get 25 RMB (≈ 4 USD) as the time reim-
bursement of survey completion. We will add partici-
pants who do not add the SESH WeChat or send them
reminder text messages according to their provided con-
tact information in the survey. After identification, we
will use Wechat or text messages to notify SHIs and ask
for their verbal consent to participate in the SD-HIVST.
Allocation and blinding
Study participants who are consented, meet inclusion
criteria, and provide non-duplicate contact information
(either cell-phone number or WeChat ID) will be ran-
domly assigned to the scale group or the machine learn-
ing group by a computer-generated program with a 1:1
allocation. Only researchers will know the details of the
group assignments, and study participants and CBO staff
are blinded.
Data collection
All MSM participants will be required to complete an
online survey during recruitment. Index participants will
need to complete two to three surveys, including a base-
line survey at their first ordering of HIVST kits, and one
to two follow-up surveys based on the times of ordering.
Alters will be asked to complete a survey when reporting
their test results. All surveys are administered online
and include electronic consent forms.
The baseline survey administered during recruitment
will include questions from the following seven perspec-
tives: sociodemographic, sexual intercourse history in
the past three months, sexual health influencer scale
[23], social network information, homoprejudiced violence
scale [27], depression scale (patient health questionnaire-
9) [28], and HIV and syphilis testing history.
The baseline survey of index participants includes add-
itional questions from the following four perspectives:
social network information, relationship with alters, ex-
periences of secondary distribution, and social support
scale [29, 30]. Questions of the survey administered to
alters will include sociodemographic, sexual intercourse
history in the past three months, the experience of
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receiving HIVST kits, previous HIV testing experience,
and social network information.
Data management
In this trial, all surveys are self-completed, and data are
stored electronically. The recruitment survey data are
stored in WENJUANXING, a popular online survey tool
in China. Data of index participants and alters are stored
in JINSHUJU, a secure online platform where individuals
can order HIVST kits, upload testing results, and fill in
surveys. Only trained CBO staff and researchers will
have access to JINSHUJU. We also assigned MSM
participants pseudonyms following a pre-determined
pattern when adding their WeChat.
Missing data plan
We will follow the intention-to-treat principle to con-
duct data analysis. Response to variables for primary and
secondary outcomes analyses are required compulsory
answers to complete the surveys. Therefore, we will not
have any missing data in terms of analyzing the primary
and secondary outcomes.
Data analysis
We will use descriptive analysis to report baseline charac-
teristics and use Shapiro-Wilk’s method for data normality
test. If the data has a normal distribution, a two-sample t-
test will be used to calculate a 95% confidence interval
(CI) to compare the differences in outcomes between the
two arms. We will use a bootstrapping method in calculat-
ing the 95% CI if the data distribution is not normal. Sub-
group analysis will be used to evaluate the difference
between the two groups in the different subsets of index
participants. We will use R version 3.6.2 software for all
the data analysis. The trial is registered with the Chinese
Clinical Trial Registry (ChiCTR2000039632).
Discussion
This quasi-experimental study will evaluate the effective-
ness of an ensemble machine learning model on identi-
fying SHIs during the digital network-based secondary
distribution of HIVST among MSM by comparing it
with an empirical scale. Digital network-based secondary
distribution leverages both social network and digital
technology, and it has been proven to be feasible and
can contribute to HIV testing uptake among MSM in
China [25, 26]. Additionally, social network interventions
for HIV prevention offer potential in the development
sector, especially in this globalizing society where people
are connected easily via social media and networking
technology [31]. Maximizing the social network
interventions by identifying the SHI might further en-
hance the sexual health behavior among MSM, more
specifically, the distribution and uptake of HIVST.
However, few studies have yet focused on it. By compar-
ing the identification methods, we can evaluate the im-
pact of the identified SHI, which could expand HIV
testing coverage, particularly to reach the marginalized
individuals or those who are reluctant to HIV and STI
testing among key populations.
Nevertheless, there are a few limitations regarding en-
semble machine-learning modeling and interventions
that should be acknowledged. One of the limitations
might be overfitting the model due to the relatively small
training and testing data sets and the comparatively large
prediction data set [22]. From the perspective of inter-
ventions, even if the HIVST kits are free, the setting of
the deposit for each test kit may potentially impede
participants from ordering and distribution, where they
might have to bear the expenditure for their peers [26].
However, we believe this strategy can effectively boost
the linkage to care services. In addition, due to the trial
design, this HIVST ordering system is only provided to
the identified SHI and limits the accessibility of all
others. However, future implementation studies can re-
solve this by removing the restriction.
The findings of our study will have significant
scientific and policy implications for the promotion of
decentralized sexual health services. The study outcomes
could contribute to optimizing the integrated digital net-
work methods on HIV and STI testing. Furthermore,
practical experience obtained from this implementation
in real-life settings might be transferable to future
initiatives to create similar self-sustaining HIV and STI
testing programs among marginalized populations. If
successful, similar peer-based or social network-based
intervention programs can use the ensemble machine
learning model for identifying the SHI to optimize
outcomes.
Trial status
We designed the study timeline to start from January
2021 to December 2021. At the time of writing this draft
protocol, the recruitment process and data collection
were ongoing. We will close the recruitment system on
August 31, 2021, and we expect to complete all follow-ups
by December 2021. Statistical analysis has not begun.
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